You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 1123 Checkpoint inhibitor administered either systemically or subcutaneously enhances the anti-tumor immunity of SD-101 delivered by PEDD device in treating liver metastasis

Alerts

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Immune-Stimulants and Immune Modulators
1123 Checkpoint inhibitor administered either systemically or subcutaneously enhances the anti-tumor immunity of SD-101 delivered by PEDD device in treating liver metastasis
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address